Search - tctmd.com

Displaying 121 - 140 of 143

Sort: Relevancy | Date

Presentation TVT 2014

Perspectives from the US CoreValve Trials

Presenter: Jeffrey J. Popma

June 07, 2014

Presentation TVT 2014

Perspectives from the PARTNER Trials

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Presenter: Samir R. Kapadia

June 07, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

Presentation TCT 2013

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

Presenter: Nicolas van Mieghem

October 28, 2013

News Daily News

No Long-term Decline in Cognitive Performance After TAVR

Jason Kahn

October 25, 2013

Presentation TVT 2013

Cerebral Embolic Protection Devices

Presenter: Eberhard Grube

June 14, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

News Daily News

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Yael L. Maxwell

May 17, 2013

News Daily News

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Yael L. Maxwell

May 17, 2013

News Daily News

Un Estudio Explora los Predictores y Consecuencias de los ACV tras una TAVR

Caitlin E. Cox

November 18, 2012

News Daily News

Study Explores Predictors, Consequences of Stroke After TAVR

Caitlin E. Cox

November 18, 2012

Presentation TCT 2012

Futuristic TAVR Devices and Cerebral Protection

Presenter: Eberhard Grube

October 25, 2012

Presentation TCT 2012

Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy

Presenter: Martyn Thomas

October 25, 2012

Presentation TCT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Samir Kapadia

October 24, 2012

News Daily News

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

August 24, 2012

Advertisement

Perspectives from the US CoreValve Trials

Perspectives from the PARTNER Trials

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

No Long-term Decline in Cognitive Performance After TAVR

Cerebral Embolic Protection Devices

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Un Estudio Explora los Predictores y Consecuencias de los ACV tras una TAVR

Study Explores Predictors, Consequences of Stroke After TAVR

Futuristic TAVR Devices and Cerebral Protection

Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content